SCHEMBL2238174

SCHEMBL2238174

COC(=O)c1cccc(NS(=O)(=O)c2ccc(-c3ccc(Cl)cc3Cl)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TCF4 P15884 2/20 0.64
CTNNB1 P35222 2/20 0.64
PFKFB3 Q16875 2/20 0.55
PFKFB4 Q16877 2/20 0.55
CYP19A1 P11511 1/20 0.53
POLB P06746 2/20 0.53
NPC1 O15118 2/20 0.52
MAPT P10636 2/20 0.52
RAB9A P51151 2/20 0.52
ATM Q13315 1/20 0.52
PLAU P00749 2/20 0.50
GPR27 Q9NS67 1/20 0.50
IDH1 O75874 1/20 0.50
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2237845 0.90 LMNA (0.63) TCF4CTNNB1PFKFB3PFKFB4CYP19A1
SCHEMBL2234325 0.89 CYP19A1 (0.56) CYP19A1POLBNPC1MAPTRAB9A
SCHEMBL2235467 0.88 POLB (0.70) PFKFB3PFKFB4CYP19A1POLBMAPT
SCHEMBL2234339 0.88 CYP19A1 (0.57) TCF4CTNNB1CYP19A1POLBMAPT
SCHEMBL10093377 0.87 CYP19A1 (0.53) TCF4CTNNB1CYP19A1POLBMAPT
SCHEMBL10093407 0.87 ATIC (0.58) TCF4CTNNB1CYP19A1POLBMAPT
SCHEMBL2236890 0.86 CYP19A1 (0.52) TCF4CTNNB1CYP19A1POLBMAPT
SCHEMBL15232983 0.81 CYP19A1 (0.57) CYP19A1MAPTGPR27IDH1LMNA
SCHEMBL10093371 0.80 TCF4 (0.64) TCF4CTNNB1PFKFB3PFKFB4POLB
SCHEMBL2236105 0.80 CYP19A1 (0.58) CYP19A1POLBMAPTGPR27BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 EP disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed
EP-2349990-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE Pimco 2664 Limited (GB) 2011-08-03 EP disclosed
WO-2010032010-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LIMITED (GB) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use SOST, PSAP, ARSA TCF4 1323/4885CTNNB1 1732/4885PFKFB3 1573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.